298 related articles for article (PubMed ID: 19347708)
21. The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer.
Pirouzpanah S; Taleban FA; Atri M; Abadi AR; Mehdipour P
Cancer Causes Control; 2010 Dec; 21(12):2101-11. PubMed ID: 20711807
[TBL] [Abstract][Full Text] [Related]
22. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
23. Association between estrogen receptor concentration in breast cancer tissue and bone mineral density.
Sriussadaporn S; Srimuninnimit V; Ploybutr S; Tanlakit M; Chearskul S; Chakrapee-Sirisuk S; Nitiyanant W; Vannasaeng S; Sinlarat P; Vichayanrat A
J Med Assoc Thai; 2002 Mar; 85(3):327-33. PubMed ID: 12117021
[TBL] [Abstract][Full Text] [Related]
24. Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma.
Prost O; Turrel MO; Dahan N; Craveur C; Adessi GL
Cancer Res; 1984 Feb; 44(2):661-4. PubMed ID: 6581863
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathological significance of aromatase expression in breast cancers].
Lu JS; Li HC; Cao DC; Di GH; Wu J; Shen KW; Shen ZZ; Shao ZM
Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1318-21. PubMed ID: 17217816
[TBL] [Abstract][Full Text] [Related]
26. Biomarkers associated with breast cancer are associated with obesity.
Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
[TBL] [Abstract][Full Text] [Related]
27. Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea.
Kim Y; Park SK; Han W; Kim DH; Hong YC; Ha EH; Ahn SH; Noh DY; Kang D; Yoo KY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):508-15. PubMed ID: 19190159
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with estrogen receptors-alpha (ER-alpha) and -beta (ER-beta) and progesterone receptor abundance in obese and non obese pre- and post-menopausal women.
Meza-Muñoz DE; Fajardo ME; Pérez-Luque EL; Malacara JM
Steroids; 2006 Jun; 71(6):498-503. PubMed ID: 16566954
[TBL] [Abstract][Full Text] [Related]
29. [Correlation between tumor tissue aromatase, histological pattern and reproductive status in patients with breast cancer].
Larionov AA; Uporov AV; Semiglazov VF; Berstein LM
Vopr Onkol; 1998; 44(1):37-42. PubMed ID: 9578729
[TBL] [Abstract][Full Text] [Related]
30. Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma.
Demirkan B; Alacacioglu A; Yilmaz U
Jpn J Clin Oncol; 2007 Apr; 37(4):256-65. PubMed ID: 17553816
[TBL] [Abstract][Full Text] [Related]
31. Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERalpha-positive breast carcinomas.
Muñoz-de-Toro M; Durando M; Beldoménico PM; Beldoménico HR; Kass L; García SR; Luque EH
Breast Cancer Res; 2006; 8(4):R47. PubMed ID: 16859517
[TBL] [Abstract][Full Text] [Related]
32. Anthropometric measures, plasma adiponectin, and breast cancer risk.
Tian YF; Chu CH; Wu MH; Chang CL; Yang T; Chou YC; Hsu GC; Yu CP; Yu JC; Sun CA
Endocr Relat Cancer; 2007 Sep; 14(3):669-77. PubMed ID: 17914097
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
Geisler J; Suzuki T; Helle H; Miki Y; Nagasaki S; Duong NK; Ekse D; Aas T; Evans DB; Lønning PE; Sasano H
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):237-41. PubMed ID: 19883757
[TBL] [Abstract][Full Text] [Related]
34. Interaction between menopausal status and obesity in affecting breast cancer risk.
Rose DP; Vona-Davis L
Maturitas; 2010 May; 66(1):33-8. PubMed ID: 20181446
[TBL] [Abstract][Full Text] [Related]
35. Obesity and risk of the less commonly diagnosed subtypes of breast cancer.
Stark A; Schultz D; Kapke A; Nadkarni P; Burke M; Linden M; Raju U
Eur J Surg Oncol; 2009 Sep; 35(9):928-35. PubMed ID: 19121564
[TBL] [Abstract][Full Text] [Related]
36. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis.
Smuc T; Pucelj MR; Sinkovec J; Husen B; Thole H; Lanisnik Rizner T
Gynecol Endocrinol; 2007 Feb; 23(2):105-11. PubMed ID: 17454161
[TBL] [Abstract][Full Text] [Related]
37. [Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer].
Bersteĭn LM; Chernobrovkina AE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Maksimov SIa; Chepik OF; Gershfel'd ED
Vopr Onkol; 2003; 49(1):55-9. PubMed ID: 12715371
[TBL] [Abstract][Full Text] [Related]
38. Estrogen-metabolizing enzymes in breast cancers from women over the age of 80 years.
Honma N; Takubo K; Sawabe M; Arai T; Akiyama F; Sakamoto G; Utsumi T; Yoshimura N; Harada N
J Clin Endocrinol Metab; 2006 Feb; 91(2):607-13. PubMed ID: 16303840
[TBL] [Abstract][Full Text] [Related]
39. [Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue].
Utsumi T
Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):920-7. PubMed ID: 2796962
[TBL] [Abstract][Full Text] [Related]
40. Expression of glucose transporter GLUT-1 and estrogen receptors ER-alpha and ER-beta in human breast cancer.
Laudański P; Koda M; Kozłowski L; Swiatecka J; Wojtukiewicz M; Sulkowski S; Wołczyński S
Neoplasma; 2004; 51(3):164-8. PubMed ID: 15254667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
